THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT07554365 updates: 1. start date: 2026-05-01 → 2026-05-13 2. enrollment: not set → 24 participants
ARGENX SE (ARGX)
Clinical trial NCT07091630: enrollment: not set → 160 participants.
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT06619847: enrollment: not set → 367 participants.
YUHAN CORPORATION (YUHNF)
Clinical trial NCT04248829 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-22 3. enrollment: not set → 393 participants
DAIICHI SANKYO CO., LTD. (DSKYF)
Clinical trial NCT05638802: enrollment: not set → 26 participants.
AMGEN INC (AMGN)
Clinical trial NCT05094336 updates: 1. completion date: 2028-05-29 → 2026-11-30 2. primary completion date: 2026-05-27 → 2026-11-30 3. enrollment: not set → 329 participants
MERCK & CO., INC. (MRK)
Clinical trial NCT05289986: enrollment: not set → 19 participants.
INCYTE CORP (INCY)
Clinical trial NCT06516952 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 349 participants
ASTRAZENECA PLC (AZN)
Clinical trial NCT03682068 updates: 1. completion date: 2026-04-29 → 2027-06-01 2. primary completion date: 2026-04-29 → 2026-06-01 3. enrollment: not set → 1246 participants
UNITED THERAPEUTICS CORP (UTHR)
Clinical trial NCT06588608 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-31 → 2026-04-24 3. primary completion date: 2026-12-31 → 2026-04-24 4. enrollment: not set → 16 participants